Literature DB >> 7824129

Assessment of MRI criteria for MS in Japanese MS and HAM/TSP.

Y Kuroda1, M Matsui, M Yukitake, K Kurohara, H Takashima, Y Takashima, C Endo, A Kato, F Mihara.   

Abstract

We evaluated the usefulness of the MRI criteria for multiple sclerosis (MS) proposed by Paty et al and Fazekas et al in 36 Japanese MS patients, using HTLV-I-associated myelopathy (HAM)/tropical spastic paraparesis (TSP) as the control. Although 30 of 36 HAM/TSP patients had multiple white matter lesions on T2-weighted cranial MRI, only two fulfilled the MRI criteria for MS. At the same time, 31 of the 36 MS patients fulfilled the primary MRI criterion, yielding 93% specificity and 86% sensitivity for the criterion. MS has disease-specific MRI abnormalities.

Entities:  

Mesh:

Year:  1995        PMID: 7824129     DOI: 10.1212/wnl.45.1.30

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  8 in total

1.  HTLV-I carrier with unusual brain MR imaging findings.

Authors:  Shinsaku Yata; Toshihide Ogawa; Shuji Sugihara; Eiji Matsusue; Shinya Fujii; Toshibumi Kinoshita
Journal:  Neuroradiology       Date:  2004-09       Impact factor: 2.804

2.  Conventional magnetic resonance imaging features in patients with tropical spastic paraparesis.

Authors:  Francesca Bagnato; John A Butman; Carlos A Mora; Shiva Gupta; Yoshima Yamano; Talin A Tasciyan; Jeffrey M Solomon; Waldyr J Santos; Roger D Stone; Henry F McFarland; Steven Jacobson
Journal:  J Neurovirol       Date:  2005-12       Impact factor: 2.643

3.  Brain magnetic resonance imaging white matter lesions are frequent in HTLV-I carriers and do not discriminate from HAM/TSP.

Authors:  Daniel J Morgan; Marina F Caskey; Cristiane Abbehusen; Jamary Oliveira-Filho; Cesar Araujo; Aurelia F Porto; Silvane Braga Santos; Gloria O Orge; Maria Jose Joia; Andre L Muniz; Isadora Siqueira; Marshall J Glesby; Edgar Carvalho
Journal:  AIDS Res Hum Retroviruses       Date:  2007-12       Impact factor: 2.205

4.  Significantly increased antibody response to heterogeneous nuclear ribonucleoproteins in cerebrospinal fluid of multiple sclerosis patients but not in patients with human T-lymphotropic virus type I-associated myelopathy/tropical spastic paraparesis.

Authors:  Motohiro Yukitake; Eisaburo Sueoka; Naoko Sueoka-Aragane; Akemi Sato; Hiromi Ohashi; Yusuke Yakushiji; Mineki Saito; Mitsuhiro Osame; Shuji Izumo; Yasuo Kuroda
Journal:  J Neurovirol       Date:  2008-04       Impact factor: 2.643

Review 5.  Treatment of HTLV-I-associated myelopathy/tropical spastic paraparesis: toward rational targeted therapy.

Authors:  Unsong Oh; Steven Jacobson
Journal:  Neurol Clin       Date:  2008-08       Impact factor: 3.806

6.  Clinical pathophysiology of human T-lymphotropic virus-type 1-associated myelopathy/tropical spastic paraparesis.

Authors:  Yoshihisa Yamano; Tomoo Sato
Journal:  Front Microbiol       Date:  2012-11-09       Impact factor: 5.640

Review 7.  Human T Lymphotropic Virus Type I (HTLV-I) Oncogenesis: Molecular Aspects of Virus and Host Interactions in Pathogenesis of Adult T cell Leukemia/Lymphoma (ATL).

Authors:  Sanaz Ahmadi Ghezeldasht; Abbas Shirdel; Mohammad Ali Assarehzadegan; Tahereh Hassannia; Hosian Rahimi; Rahele Miri; S A Rahim Rezaee
Journal:  Iran J Basic Med Sci       Date:  2013-03       Impact factor: 2.699

8.  Encephalomyelopathy associated with HTLV-I a primary disease or coexisting with multiple sclerosis?

Authors:  Ana Paula Silva Champs; Valéria Maria de Azeredo Passos; Sandhi Maria Barreto; Paulo Caramelli; Carla Meirelles de Melo; Guilherme Carvalho; Miriam Melo Menezes; João Gabriel Ramos Ribas
Journal:  Dement Neuropsychol       Date:  2013 Oct-Dec
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.